You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Johnson and Johnson
Dow
McKesson
McKinsey

Last Updated: November 26, 2020

DrugPatentWatch Database Preview

ALFERON N INJECTION Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ALFERON N INJECTION
Recent Clinical Trials for ALFERON N INJECTION

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Hemispherx BiopharmaPhase 2
Henry M. Jackson Foundation for the Advancement of Military MedicinePhase 1
National Institute of Allergy and Infectious Diseases (NIAID)N/A

See all ALFERON N INJECTION clinical trials

Pharmacology for ALFERON N INJECTION
Ingredient-typeInterferon-alpha

Patent Text Search: US Patents for ALFERON N INJECTION

These patents were identified by searching patent claims

International Patents for ALFERON N INJECTION

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
AstraZeneca
Johnson and Johnson
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.